Resources

SQ – Base Case iCDS 65bps, Negative Case iCDS 148bps, 2027 0.250% Bond YTW of 5.627%, iYTW of 4.740%, Ba2 Rating from Moody’s, IG4+ (equivalent to Baa1) Rating from Valens, Low Refinancing Need

March 18, 2024

  • Credit markets are materially overstating SQ’s credit risk with a YTW of 5.627% relative to an Intrinsic YTW of 4.740% and an Intrinsic CDS of 65bps. Furthermore, Moody’s is overstating SQ’s fundamental credit risk with its speculative Ba2 credit rating four notches below Valens’ IG4+ (Baa1) credit rating.
  • Incentives Dictate Behavior™ analysis highlights mixed signals for credit holders. As positives, most management members are material owners of SQ equity relative to their annual compensation, indicating they may be aligned with shareholders to pursue long-term value creation for the company. Also, most members of management have low change-in-control compensation relative to their annual compensation. This indicates that they may not be incentivized to pursue or accept a takeover or sale of the company, decreasing event risk for creditors.
  • Earnings Call Forensics™ of SQ’s Q4 2023 (02/22/2023) call highlights that management is confident generated an excitement marker when saying their key growth initiatives provide the opportunities to outperform their initial guidance. In addition, they are confident they are less than 1% penetrated in international markets with a long runway for growth, that they achieved a record 24% gross profit margin and that they expect one point of outperformance this year in either gross profit or adjusted operating income margin expansion.

You don’t have access to the Valens Research Premium Application.

To get access to our best content including the highly regarded Conviction Long List and Market Phase Cycle macro newsletter, please contact our Client Relations Team at 630-841-0683 or email client.relations@valens-research.com.

Please fill out the fields below so that our client relations team can contact you

Or contact our Client Relationship Team at 630-841-0683